Affiliation:
1. Department of Dermatology and Skin Cancer and Unit of Cell and Gene Therapy Nantes University Hospital Nantes France
2. Department of Dermatology Elbe‐Kliniken Buxtehude Buxtehude Germany
3. Pharmacie Principale SICARD Châlons‐en‐Champagne France
4. Centre for Rare Diseases – South Region Skåne University Hospital Lund Sweden
5. Asociación Melanoma España Barcelona Spain
6. Pierre Fabre Dermo‐Cosmétique Corporate Patient Centricity Lavaur France
7. Pierre Fabre Médicament Boulogne‐Billancourt France
Abstract
AbstractIn recent years, new approaches for optimal patient management of cancer have focused on patient‐centered care, with integration of tumour‐directed treatment and patient‐directed supportive and palliative care throughout the disease journey from prevention through screening, diagnosis, treatment, and follow‐up. In 2022, at the International Forum of Dermatology (IFD), a scientific session was entirely dedicated to highlight recent developments on patient‐centered approaches in skin cancer. An international panel of different groups of participants involved in a patient's journey on the management of skin cancer presented and discussed challenges and barriers that persist in the field of skin cancer prevention and care pathways. Although primary prevention remains a crucial step in the prevention of melanoma, the different surveys performed during the last 20 years demonstrate that the use of sunscreen increases very slowly. Secondary prevention that includes skin screening and diagnostic measures may benefit from the development of digital tools. To improve adherence, patients need accurate, reliable information about their disease and the treatment options, and this type of content that can also be made available on digital tools. Shared decision‐making is a hallmark of a patient‐centered approach and requires health care providers who can communicate well to patients and their families, underscoring the pivotal role of health care professionals all through the patient journey. Health care providers have a crucial role in supporting patients through their journey in skin cancer. They will benefit from mobile apps and technologies that have been developed recently to address challenges in skin cancer prevention, detection and care, including those that are primarily directed to the patient. However, more peer‐reviewed studies are needed as well as regulations to ensure that apps are accurate, reliable, and up to date.
Reference32 articles.
1. The global burden of skin cancer: a longitudinal analysis from the global burden of disease study, 1990–2017;Urban K;JAAD Int,2021
2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA Cancer J Clin,2021
3. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology;Bickers DR;J Am Acad Dermatol,2006
4. Prevalence and costs of skin cancer treatment in the US, 2002‐2006 and 2007‐2011;Guy GP;Am J Prev Med,2015
5. Global burden of cutaneous melanoma in 2020 and projections to 2040;Arnold M;JAMA Dermatol,2022